Literature DB >> 28441039

High-Throughput Processing to Preserve Viable Cells: A Precision Medicine Initiative Cohort Program Workshop.

Rebekah S Rasooly1, Daniel R Gossett1, Marianne K Henderson2, Allison Hubel3, Stephen N Thibodeau4.   

Abstract

Conventionally, biobanks supporting clinical research studies have preserved serum, plasma, urine, saliva, a variety of tissue types, and stool. With the emergence of increasingly sophisticated technologies for analyzing single cells, there is growing interest in preserving viable blood cells for future functional studies. The new All of Us Research Program (formerly the Precision Medicine Initiative Cohort Program) biobank plans to house samples from a million or more individuals as part of a cohort with rich phenotypic data and longitudinal follow-up ( www.nih.gov/research-training/allofus-research-program ). Storage of viable cells for future single-cell analysis offers the promise of new biology, discovery of novel biomarkers, and advances toward the goal of precision medicine. A workshop was held in the summer of 2016 to evaluate the case for preservation of viable mononuclear blood cells and its feasibility within the collection plan for the biobank.

Keywords:  biomarkers; cell preservation; cell viability; high-throughput; precision medicine; single-cell analysis

Mesh:

Year:  2017        PMID: 28441039      PMCID: PMC5582583          DOI: 10.1089/bio.2017.0016

Source DB:  PubMed          Journal:  Biopreserv Biobank        ISSN: 1947-5543            Impact factor:   2.300


  13 in total

1.  Transportation of cellular therapy products: report of a survey by the cellular therapies team of the Biomedical Excellence for Safer Transfusion (BEST) collaborative.

Authors:  D H Pamphilon; E Selogie; Z M Szczepiorkowski
Journal:  Vox Sang       Date:  2010-03-10       Impact factor: 2.144

2.  Efficient cryopreservation of human pluripotent stem cells by surface-based vitrification.

Authors:  Julia C Neubauer; Axel F Beier; Niels Geijsen; Heiko Zimmermann
Journal:  Methods Mol Biol       Date:  2015

3.  Method validation for automated isolation of viable peripheral blood mononuclear cells.

Authors:  Gael Hamot; Wim Ammerlaan; Conny Mathay; Olga Kofanova; Fay Betsou
Journal:  Biopreserv Biobank       Date:  2015-04-01       Impact factor: 2.300

4.  Biomarker failures.

Authors:  John P A Ioannidis
Journal:  Clin Chem       Date:  2012-09-20       Impact factor: 8.327

5.  Multiparameter Phenotyping of Human PBMCs Using Mass Cytometry.

Authors:  Michael D Leipold; Evan W Newell; Holden T Maecker
Journal:  Methods Mol Biol       Date:  2015

6.  Global analyses of human immune variation reveal baseline predictors of postvaccination responses.

Authors:  John S Tsang; Pamela L Schwartzberg; Yuri Kotliarov; Angelique Biancotto; Zhi Xie; Ronald N Germain; Ena Wang; Matthew J Olnes; Manikandan Narayanan; Hana Golding; Susan Moir; Howard B Dickler; Shira Perl; Foo Cheung
Journal:  Cell       Date:  2014-04-10       Impact factor: 41.582

Review 7.  Cellular Deconstruction: Finding Meaning in Individual Cell Variation.

Authors:  James Eberwine; Junhyong Kim
Journal:  Trends Cell Biol       Date:  2015-10       Impact factor: 20.808

Review 8.  Isolation and preservation of peripheral blood mononuclear cells for analysis of islet antigen-reactive T cell responses: position statement of the T-Cell Workshop Committee of the Immunology of Diabetes Society.

Authors:  R Mallone; S I Mannering; B M Brooks-Worrell; I Durinovic-Belló; C M Cilio; F S Wong; N C Schloot
Journal:  Clin Exp Immunol       Date:  2010-10-05       Impact factor: 4.330

9.  Single-cell transcriptomes identify human islet cell signatures and reveal cell-type-specific expression changes in type 2 diabetes.

Authors:  Nathan Lawlor; Joshy George; Mohan Bolisetty; Romy Kursawe; Lili Sun; V Sivakamasundari; Ina Kycia; Paul Robson; Michael L Stitzel
Journal:  Genome Res       Date:  2016-11-18       Impact factor: 9.043

10.  Characterizing biobank organizations in the U.S.: results from a national survey.

Authors:  Gail E Henderson; R Jean Cadigan; Teresa P Edwards; Ian Conlon; Anders G Nelson; James P Evans; Arlene M Davis; Catherine Zimmer; Bryan J Weiner
Journal:  Genome Med       Date:  2013-01-25       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.